Revisão sistemática | Benefícios e prejuízos do rastreamento mamográfico anual, bienal e trienal para mulheres na média de risco para câncer de mama.
9 Dez, 2021 | 15:20h
Comentário no Twitter (fio – clique para saber mais)
Our comprehensive #systematicreview for the #ECIBC on intervals (every 1, 2, 3 years) of #breastcancer #screening is available.
We included RCT, observational, and mathematical modeling studies to assess benefits and harms and applied the #GRADE approachhttps://t.co/IfplsWfKuA pic.twitter.com/7niEbnaWKR— Carlos Canelo-Aybar (@ccaneloa) November 27, 2021